Profile data is unavailable for this security.
About the company
Cyberdyne Inc is engaged in the research, development, manufacture, sale, and maintenance management related to Cybernics technology. The Company mainly uses human and the Internet of Things (IoH/IoT), robots, and artificial intelligence (AI) Cybernics technology to develop Cybernic systems. It develops the Cybernics treatment service business and the training service business that utilize Cybernics technology. The Company develops in various fields centered on HAL. HAL is a robot treatment device for the purpose of improving and regenerating the physical function of patients, a welfare device and life support device for the purpose of supporting independence, and a work support equipment. It can be used for various purposes by being worn and used by people. The Company is also involved in the productization of AI-equipped transport robots; cleaning robots; Cyin, which is used for communication with people with disabilities, and electrocardiography devices.
- Revenue in JPY (TTM)4.35bn
- Net income in JPY-1.48bn
- Incorporated2004
- Employees227.00
- LocationCyberdyne Inc2-2-1, Gakuen-MinamiTSUKUBA-SHI 305-0818JapanJPN
- Phone+81 298553189
- Fax+81 298553181
- Websitehttps://www.cyberdyne.jp/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| StemCell Institute Inc | 2.48bn | 310.98m | 16.80bn | 98.00 | 54.04 | 6.24 | 38.94 | 6.77 | 30.35 | 30.35 | 242.15 | 262.78 | 0.4017 | 22.19 | 1.82 | 25,318,300.00 | 5.03 | 4.23 | 12.05 | 10.85 | 63.51 | 64.40 | 12.53 | 10.41 | 1.19 | -- | 0.0033 | 0.00 | 18.64 | 16.63 | 57.04 | 16.84 | 46.68 | -- |
| Saint-Care Holding Corp | 54.06bn | 2.01bn | 22.30bn | 4.74k | 11.10 | 1.37 | 7.42 | 0.4125 | 80.34 | 80.34 | 2,165.67 | 650.05 | 1.79 | 395.13 | 6.50 | 11,409,260.00 | 6.63 | 5.91 | 9.00 | 7.99 | 12.90 | 12.93 | 3.71 | 3.22 | 2.07 | 21.26 | 0.2446 | 31.53 | 2.86 | 5.63 | 17.04 | 16.58 | -3.20 | 12.30 |
| Falco Holdings Co Ltd | 43.01bn | 1.67bn | 26.06bn | 1.12k | 15.55 | 0.9645 | 9.85 | 0.606 | 151.25 | 151.25 | 3,893.06 | 2,438.54 | 1.14 | 20.60 | 6.67 | 38,502,240.00 | 4.43 | 5.79 | 5.75 | 7.95 | 30.05 | 31.28 | 3.88 | 4.66 | 2.29 | -- | 0.0304 | 38.78 | -8.33 | -0.5259 | -26.32 | 20.60 | 0.8937 | 11.70 |
| Cyberdyne Inc | 4.35bn | -1.48bn | 29.14bn | 227.00 | -- | 1.10 | -- | 6.69 | -7.00 | -7.00 | 20.62 | 193.02 | 0.0869 | 1.97 | 7.38 | 19,176,210.00 | -3.29 | -1.14 | -3.36 | -1.16 | 54.95 | 61.14 | -37.88 | -20.68 | 14.14 | -- | 0.0154 | -- | 32.38 | 20.57 | -395.30 | -- | -22.40 | -- |
| CellSource Co Ltd | 4.57bn | 813.06m | 30.05bn | 151.00 | 36.42 | 4.93 | 33.04 | 6.58 | 41.65 | 41.65 | 232.98 | 307.83 | 0.7816 | 6.43 | 11.51 | 30,249,040.00 | 13.91 | 19.23 | 15.46 | 22.57 | 67.15 | 70.75 | 17.80 | 20.21 | 9.12 | -- | 0.00 | 12.89 | 5.54 | 30.04 | -9.30 | 36.70 | 70.54 | -- |
| I'rom Group Co Ltd | 17.74bn | 1.42bn | 34.21bn | 1.03k | 23.73 | 2.63 | 13.41 | 1.93 | 116.87 | 116.87 | 1,465.20 | 1,054.90 | 0.4909 | 13.33 | 5.02 | 17,240,040.00 | 3.92 | 6.94 | 5.97 | 9.87 | 42.31 | 43.17 | 7.98 | 11.34 | 1.18 | -- | 0.6098 | 31.02 | -3.33 | 10.89 | -44.34 | 9.18 | 16.61 | 14.87 |
| Value HR Co Ltd | 7.33bn | 896.98m | 39.88bn | 676.00 | 42.56 | 6.28 | 31.98 | 5.44 | 34.21 | 34.21 | 279.18 | 232.00 | 0.4486 | 55.35 | 10.38 | 10,840,370.00 | 5.49 | 4.83 | 7.60 | 6.75 | 39.86 | 40.54 | 12.23 | 12.79 | 1.19 | -- | 0.4887 | 51.76 | 15.11 | 14.62 | 10.13 | 31.90 | -40.85 | 31.95 |
| Holder | Shares | % Held |
|---|---|---|
| Sawakami Asset Management, Inc.as of 30 Apr 2024 | 1.69m | 1.23% |
| Simplex Asset Management Co., Ltd.as of 04 Jul 2024 | 622.50k | 0.45% |
| Dimensional Fund Advisors LPas of 04 Jul 2024 | 442.30k | 0.32% |
| Global X Japan Co., Ltd.as of 05 Jul 2024 | 130.20k | 0.10% |
| Nikko Asset Management Co., Ltd.as of 20 Jan 2023 | 87.00k | 0.06% |
| AcomeA SGR SpAas of 30 Jun 2023 | 81.80k | 0.06% |
| SSgA Funds Management, Inc.as of 03 Jul 2024 | 79.30k | 0.06% |
| Vanguard Global Advisers LLCas of 31 May 2024 | 51.60k | 0.04% |
| Northern Trust Global Investments Ltd.as of 30 Apr 2024 | 50.70k | 0.04% |
| UBS Asset Management (UK) Ltd.as of 28 Mar 2024 | 42.30k | 0.03% |
